Combined medical–phototherapy treatments, such as verapamil, ultraviolet A1 phototherapy in the wavelength range of 340–400 nm, and angiotensin‐converting enzyme inhibitors (ACEIs), as well as the application of new technologies, have been shown to significantly inhibit fibroblast proliferation in keloids [37, 38]. The gene discussed is ACE; the disease is keloid.